Neurotossicità dei mezzi di contrasto iodati

Abstract

English

I m.d.c. iodati impiegati nelle indagini neuroradiologiche presentano una neurotossicità che dipende sia dalla via di introduzione che dal contrasto usato. I m.d.c. non ionici e quelli a bassa osmolarità, pur non essendo privi di effetti collaterali, si dimostrano adeguati a soddisfare tutte le esigenze diagnostiche e presentano una buona tollerabilità.

Keywords

mezzi di contrasto effetti collaterali neuroradiologia

Get full access to this article

View all access options for this article.

References

Battistin

Zanchin

: Aspetti fisiopatologici e clinici della barriera emato-encefalica. Federazione medica 5:534–544, 1985.

Caillé

Guibert-Trainer

Howa

: Cerebral penetration following metrizamide myelography. J Neuroradiol 7:3–12, 1980.

Caillé

Gioux

: Neurotoxicity of Nonionic Iodinated Water-Soluble Contrast Media in Myelography: Experimental Study. AJNR 4:1185–1189, 1983.

Carchietti

Baldassarre

: Iopamidol 300 - induced epilepsy: Intensive treatment and pathogenic hypothesis. Neuroradiology 30:256–257, 1988.

Gelmers

: Adverse side effects of metrizamide in myelography. Neuroradiology 18:119–123, 1979.

Hammer

: The pathophysiology of intrathecally injected contrast media. In: Felix

Kazner

Wegener

(Eds) Contrast media in computed tomography. Excerpta Medica, Amsterdam, 1981, pp. 52–57.

Hauge

Falkenberg

: Neuropsychologic Reactions and Other Side Effects After Metrizamide Myelography. AJNR 3:229–232, 1982.

Hayman

Evans

: Delayed high dose contrast CT: identifying patients at risk of massive hemorrhagic infarction. AJR 136:1151–1159, 1981.

Kekster

REM

Prins

Pennings-Braun

AGM

: Lumbar myelography with metrizamide. Acta Radiol 355:357–360, 1977.

10.

Higgins

Schmidt

: Identification and evaluation of the contribution of the chemoreflex in the hemodynamic response to intracarotid administration of contrast materials in the consciuous dog: comparison with the response to nicotine. Invest Radiol 14:438–446, 1979.

11.

Hindmarsh

: Elimination of water-soluble contrast media from a subarachnoidal space: investigation with computer tomography. Acta Radiol 346:45, 1975.

12.

Hoffmann

Becker

, and Wenzel-Hora

: Influence of the spread and period of retention of Iotrolan in the subarachnoid space on the side effects rate in myelography. Neuroradiology 29:380–384, 1987.

13.

Hoppe

: Some pharmacological aspects of radiopaque compounds. Ann NY Acad Sci 78:727–739, 1959.

14.

Irstam

: Lumbar myelography with Amipaque. Spine 3:70–82, 1978.

15.

Jeppson

Olin

: Neurotoxicity of roentgen contrast media: study of the brain-blood barrier following selective injection of contrast media into the internal carotid artery. Acta Radiol 10:17–34, 1970.

16.

Kendall

Pullicino

: Intravascular contrast injection in ischaemic lesion. II. Effect on prognosis. Neuroradiology 19:241–243, 1980.

17.

Kerber

Sovak

: Iotrol, a new myelographic agent: Q. Radiography, CT, CSF clearance, and brain penetration. AJNR 4:317–318, 1983.

18.

Lee

BCP

Gomez

: Subacute reactions intrathecal amipaque, metrizamide, Conray, and Dimer-X: a structural and ultrastructural study. Neuroradiology 20:229, 1981.

19.

Lynch

Harrington

Michie

: Cardiovascular reflexes assaciated with cerebral angiography. Invest Radiol 4:156–160, 1969.

20.

Lozito

: Convulsions: a complication of contrast enhancement in computerized tomography. Arch. Neurol. 34:649–650, 1977.

21.

Marder

O'Neil

: Cholinergic Actions of Metrizamide. AJNR 4:61–65, 1983.

22.

Moschini

Manara

: Iopamidol and Metrizamide in Cervical Myelography: Side Effects, EEG, and CSF Changes. AJNR 4:848–850, 1983.

23.

Pullicino

Kendall

: Contrast enhancement in ischaemic lesions. I. Relationship to prognosis. Neuroradiology 19:235–239, 1980.

24.

Rapoport

Fredericks

: Quantitative aspects of reversible osmotic opening of the blood-brain barrier. Am J Physiol 238:421–431, 1980.

25.

Rapoport

Thompson

Bidinger

: Equi-osmolal opening of the blood-brain barrier in the rabbit by different contrast media. Acta Radiol 15:21–32, 1974.

26.

Sage

Wilcox

: Comparison and evaluation of osmotic blood-brain barrier disruption following intracarotid mannitol and methylglucamine iothalamate. Invest Radiol 17:276–281, 1982.

27.

Sage

Wilcox

: Brain Parenchyma Penetration by Intrathecal Nonionic Iopamidol. AJNR 4:1181–1183, 1983.

28.

Sand

Anda

: Chemical meningitis in metrizamide myelography. A report of seven cases. Neuroradiology 28:69–71, 1986.

29.

Sand

Stovner

: Side effects after diagnostic lumbar puncture and lumbar iohexol myelography. Neuroradiology 29:385–388, 1987.

30.

Scott

: Seizures: a reaction to contrast media for computed tomography of the brain. Radiology 137:359–361, 1980.

31.

Skalpe

: Adverse effects of water soluble contrast media in myelography, cisternography, and ventriculography. Acta Radiol. 355: 280–293, 1977.

32.

Skalpe

: Complications in cerebral angiography with iohexol (Omnipaque) and meglumine metrizoate (Isopaque cerebral). Neuroradiology 30:69–72, 1988.

33.

Skalpe

and Nakstad

: Myelography with Iohexol (Omnipaque); A clinical report with special reference to the adverse effects. Neuroradiology 30:169–174, 1988.

34.

Sovak

Ranganathan

Hammer

: Early experience with iotrol, nonionic isotonic dimer for intrathecal space. Invest Radiol 19: S139–S140, 1984.

35.

Sovak

: Radiocontrast Agents. Springer-Verlag, 1984.

36.

Studer

Welch

Siegel

: Transient alteration of the blood-brain barrier: effect of hypertonic solutions administered via carotid artery injection. Exp Neurol 44:266–273, 1974.

37.

Wilcox

Wilson

: A Comparison of Blood-Brain Barrier Disruption by Intracarotid Iohexol and Iodixanol in the Rabbit. AJNR 8:769–772, 1987.

38.

Junck

Marshall

: Neurotoxicity of Radiological contrast Agents. Ann of Neurol 13:469–484, 1983.